SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Gold/Mining/Energy : Inflazyme Pharmaceuticals (T.IZP)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Sean Janzen who wrote (966)6/5/1998 2:37:00 PM
From: Harold Lehman  Read Replies (1) of 1501
 
You can hold the calls to Dr. Michael Flynn, President of Cortecs. He called me back this morning regarding the tb antigen test. He first checked with their Diagnostics Director, who told him that there's been no adverse event or adverse change of any kind since the last public statement was made. He didn't know when that was or if there's been any public statement since the collaboration was announced as he has 60-70 projects going on. They've done a lot of work, and as far as they're concerned everything is fine with the collaboration. Everything is progressing well and they're not expecting to hear anything negative. If there is anything negative it would merit a public statement, and there's nothing like that that they're aware of at all.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News